Belgium

Belgium-based drugmaker

Doctors in Belgium are largely keeping in line with government targets for prescribing generic medicines, according to national health insurer Inami. As a result,

Belgium industrial conglomerate Solvay recorded strong results in 2006, driven by surging sales for its pharmaceuticals division. Turnover in 2006 reached EUR9.4bn (US$12.3bn),... 2007-02-22

As part of a restructuring programme for its European operations, US firm Eli Lilly has simultaneously closed its R&D facility in Belgium and announced the construction of biopharmaceutical... 2006-12-05

The Belgium government has finalised the health insurance budget for next year, ensuring that more people on low incomes will receive a larger rebate on doctors' fees and medicine... 2006-11-07

To enter the expanding Central and Eastern Europe over-the-counter (OTC) medicines market, Belgian firm Omega Pharma has acquired Austrian consumer healthcare company Bittner Pharma.... 2006-10-26

Continuing the consolidation trend in the European pharmaceutical sector, Belgian firm UCB has unveiled a EUR4.4bn (US$5.6bn) bid for German company Schwarz Pharma to create major... 2006-10-04

In a victory for small, innovative biotechnology companies, a US federal jury has awarded Belgian biotech firm Innogenetics US$7mn in damages after determining that US-based Abbott... 2006-09-18

Matching compatriot firm Solvay, Belgian drugmaker UCB has released strong financial results for the first half of 2006 in which revenues increased by 12% to EUR1.3bn (US$1.7bn).... 2006-08-02

On the back of robust first half of 2006 financial results, Belgian pharmaceutical and chemical group Solvay intends to expand its reach in its faster growing markets, specifically... 2006-08-02